Primary Record
Cucurbitacin E
- In stock
- 4,911 g
- Purity
- 98.6 %
- CAS
- 18444-66-1
Compound Identifiers & Properties
- CAS
- 18444-66-1
- PubChem CID
- 5281319
- SMILES
- CC(=O)OC(C)(C)/C=C/C(=O)[C@@](C)([C@H]1[C@@H](C[C@@]2([C@@]1(CC(=O)[C@@]3([C@H]2CC=C4[C@H]3C=C(C(=O)C4(C)C)O)C)C)C)O)O
- Canonical SMILES
- CC(=O)OC(C)(C)/C=C/C(=O)[C@](C)(O)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC=C4[C@@H](C=C(O)C(=O)C4(C)C)[C@]3(C)C(=O)C[C@]12C
Names & Synonyms
- Cucurbitacin E
- alpha-Elaterin
- alpha-Elaterine
- Cucurbitacine-E
- 18444-66-1
- Cucurbitacine E
- .alpha.-Elaterin
- Cucurbitacin-E
- a-Elaterin
- .alpha.-Elaterine
- ELATERIN, ALPHA
- -Elaterin;-Elaterine
- AC1NQYC4
- RefChem:128717
- UNII-V8A45XYI21
- V8A45XYI21
- Cucurbitacin E (Standard)
- CHEBI:3944
- CUCURBITACIN E [MI]
- (-)-CUCURBITACIN E
- C32H44O8
- NSC 106399
- NSC-106399
- SCHEMBL140616
- MFCD00135936
- CHEMBL455056
- DTXSID601030496
- orb1301289
- Cucurbitacin E (alpha-Elaterin)
- NSC-521775
- EINECS 242-325-2
- HY-N0417R
- NDYMQXYDSVBNLL-MUYMLXPFSA-N
- DTXCID701529571
- HY-N0417
- ZINC4097800
- BRN 2343323
- LMST01010107
- NP7222
- NSC106399
- NSC521775
- AKOS015896851
- ACN-035422
- C32-H44-O8
- CID5281319
- CS-3817
- FC69737
- CID:5281319
- CUCURBITACIN E (REFERENCE GRADE)
- AC-34285
- AS-76174
- DA-72424
- J14.209C
- SID:176223207
- FT-0697873
- FT-0776601
- N2791
- NS00094068
- Y0059
- 4-08-00-03731 (Beilstein Handbook Reference)
- C08797
- 19-Norlanosta-1,5,23-triene-3,11,22-trione,25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-, (9b,10a,16a,23E)-
- 444C661
- A930353
- C102326
- [(E,6R)-6-[(8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate
- I07-0167
- Q5192451
- Cucurbitacin E, 98%, from Cucumis melo L. - 5MG 5mg
- (R,E)-6-((8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-4,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate
- 19-Norlanosta-1,5,23-triene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-, (9beta,10alpha,16alpha,23E)-
- CUE
- 19-Norlanosta-1,5,23-triene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-, (9.beta.,10.alpha.,16.alpha.,23E)-
- 2,16alpha,20,25-Tetrahydroxy-9beta-methyl-10alpha,-19-norlanosta-1,5,23(E)-triene-3,11,22-trione 25-acetate
- 25-(Acetyloxy)-2,16,20-trihydroxy-9-methyl-19-norlanosta-1,5,23-triene-3,11,22-trione (9beta,10alpha,16alpha,23E)-
- ((E,6R)-6-((8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta(a)phenanthren-17-yl)-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl) acetate
- (10alpha,23E)-25-(Acetyloxy)-2,16alpha,20-trihydroxy-9beta-methyl-19-norlanosta-1,5,23-triene-3,11,22-trione
- (23E)-25-acetyloxy-2,16alpha,20-trihydroxy-9beta-methyl-19-nor-10alpha-lanosta-1,5,23-triene-3,11,22-trione
- (3E,6R)-6-[(1R,2R,3aS,3bS,9aR,9bR,11aR)-2,8-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1H,2H,3H,3aH,3bH,4H,6H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate
- (4R,23E)-2,16alpha,20-trihydroxy-9beta,10,14-trimethyl-1,11,22-trioxo-4,9-cyclo-9,10-secocholesta-2,5,23-trien-25-yl acetate
- (9.BETA.,10.ALPHA.,16.ALPHA.,23E)-25-(ACETYLOXY)-2,16,20-TRIHYDROXY-9-METHYL-19-NORLANOSTA-1,5,23-TRIENE-3,11,22-TRIONE
- (9beta,10alpha,23E)-25-(Acetyloxy)-2,16alpha,20-trihydroxy-9-methyl-19-norlanosta-1,5,23-triene-3,11,22-trione
- (9beta,10alpha,23E)-25-Acetyloxy-2,16alpha,20-trihydroxy-9-methyl-19-norlanosta-1,5,23-triene-3,11,22-trione
- [(E,5R)-5-[(8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxo-hex-2-enyl] acetate
- 19-Nor-9-beta,10-alpha-lanosta-1,5,23-triene-3,11,22-trione, 2,16-alpha,20,25-tetrahydroxy-9-methyl-, 25-acetate
- 19-Nor-9.beta.,10.alpha.-lanosta-1,5,23-triene-3,11,22-trione, 2,16.alpha.,20,25-tetrahydroxy-9-methyl-, 25-acetate
- 19-Nor-9.beta.,5,23-triene-3,11,22-trione, 2,16.alpha.,20,25-tetrahydroxy-9-methyl-, 25-acetate
- 19-Nor-9beta,10alpha-lanosta-1,5,23-triene-3,11,22-trione, 2,16alpha,20,25-tetrahydroxy-9-methyl-, 25-acetate
- 19-Norlanosta-1,23-triene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-, (9.beta.,10.alpha.,16.alpha.,23E)-
- 2,16alpha,20,25-tetrahydroxy-9-methyl-19-nor-9beta,10alpha-lanosta-1,5,23-triene-3,11,22-trione 25-acetate
- 242-325-2
- Cucurbitacine E; NSC 106399; NSC 521775; |A- Elaterin; |A-Elaterine; 19-Norlanosta-1,5,23-triene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-, (9B,10a,16a,23E)-; (R,E)-6-((8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-4,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate